Besson J - Search Results

1

Characterization of vasoactive intestinal peptide receptors by a photoaffinity label. Site-specific modification of vasoactive intestinal peptide by derivatization of the receptor-bound peptide.

Robichon A, Kuks PF, Besson J. Robichon A, et al. Among authors: besson j. J Biol Chem. 1987 Aug 25;262(24):11539-45. J Biol Chem. 1987. PMID: 3040706 Free article.

2

[Intestinal vasoactive peptide receptors in enterocytes : specific binding and stimulation of cyclic AMP].

Laburthe M, Besson J, Bon Hoa DH, Rosselin G. Laburthe M, et al. Among authors: besson j. C R Acad Hebd Seances Acad Sci D. 1977 Jun 6;284(21):2139-42. C R Acad Hebd Seances Acad Sci D. 1977. PMID: 195749 French.

3

Distribution and pharmacology of vasoactive intestinal peptide receptors in the brain and pituitary.

Besson J. Besson J. Ann N Y Acad Sci. 1988;527:204-19. doi: 10.1111/j.1749-6632.1988.tb26982.x. Ann N Y Acad Sci. 1988. PMID: 2839077 Review. No abstract available.

4

Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system.

Besson J, Sarrieau A, Vial M, Marie JC, Rosselin G, Rostene W. Besson J, et al. Brain Res. 1986 Nov 29;398(2):329-36. doi: 10.1016/0006-8993(86)91493-9. Brain Res. 1986. PMID: 3801907

5

[Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].

Bataille D, Peillon F, Besson J, Rosselin G. Bataille D, et al. Among authors: besson j. C R Seances Acad Sci D. 1979 May 7;288(17):1315-7. C R Seances Acad Sci D. 1979. PMID: 225051 French.

6

Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.

Epelbaum J, Tapia-Arancibia L, Besson J, Rotsztejn WH, Kordon C. Epelbaum J, et al. Among authors: besson j. Eur J Pharmacol. 1979 Oct 15;58(4):493-5. doi: 10.1016/0014-2999(79)90323-6. Eur J Pharmacol. 1979. PMID: 510382

7

Release of vasoactive intestinal peptide from rat jejuno-ileum in vitro. Effect of various depolarizing agents.

Besson J, Rostene W, Lhiaubet AM, Poussin B, Rosselin G. Besson J, et al. Experientia. 1983 Jul 15;39(7):732-3. doi: 10.1007/BF01990297. Experientia. 1983. PMID: 6861958

8

Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase.

Besson J, Malassiné A, Ferré F. Besson J, et al. Regul Pept. 1987 Nov;19(3-4):197-207. doi: 10.1016/0167-0115(87)90276-x. Regul Pept. 1987. PMID: 2829291

9

Vasoactive intestinal polypeptide: presence in neuroblastoma X glioma hybrid cells.

Glaser T, Besson J, Rosselin G, Hamprecht B. Glaser T, et al. Among authors: besson j. Eur J Pharmacol. 1983 May 20;90(1):121-3. doi: 10.1016/0014-2999(83)90222-4. Eur J Pharmacol. 1983. PMID: 6873174

10

[Vasoactive intestinal polypeptide (VIP) tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay (author's transl)].

Besson J, Dupont C, Laburthe M, Bataille D, Rosselin G. Besson J, et al. Ann Endocrinol (Paris). 1977 Mar-Apr;38(2):145-6. Ann Endocrinol (Paris). 1977. PMID: 900867 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

662 results

Search Page

Filters